APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Rabies Immunoglobulin (IM)

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)

Selected research

Market Analysis & Forecast

Global Human Rabies Immunoglobulin (IM) Market Analysis and Forecast 2026-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchHuman Rabies Immunoglobulin (IM) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Rabies Immunoglobulin (IM) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Human Rabies Immunoglobulin (IM) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Rabies Immunoglobulin (IM) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Rabies Immunoglobulin (IM) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)

Read the full market overview

Global Human Rabies Immunoglobulin (IM) key players include CSL Behring, Grifols, Sanofi, etc. Global top three manufacturers hold a share about 60%.

North America is the largest market, with a share over 30%, followed by China and Europe, both have a share about 45 percent.

In terms of product, HRIG is the largest segment, with a share over 85%. And in terms of application, the largest application is Category III Exposure, followed by Category II Exposure.

This report presents an overview of global market for Human Rabies Immunoglobulin (IM), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Rabies Immunoglobulin (IM), also provides the sales of main regions and countries. Of the upcoming market potential for Human Rabies Immunoglobulin (IM), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Rabies Immunoglobulin (IM) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Rabies Immunoglobulin (IM) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Rabies Immunoglobulin (IM) sales, projected growth trends, production technology, application and end-user industry.

Human Rabies Immunoglobulin (IM) Segment by Company

CSL Behring

Grifols

Sanofi

Sichuan Yuanda Shuyang

CNBG

Kamada

CBPO

Shuanglin Bio

Weiguang Bio

Shanghai RAAS

Bharat Serum

VINS

Human Rabies Immunoglobulin (IM) Segment by Type

ERIG

HRIG

Human Rabies Immunoglobulin (IM) Segment by Application

Category II Exposure

Category III Exposure

Human Rabies Immunoglobulin (IM) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rabies Immunoglobulin (IM) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Rabies Immunoglobulin (IM) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rabies Immunoglobulin (IM).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Rabies Immunoglobulin (IM) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Rabies Immunoglobulin (IM) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Rabies Immunoglobulin (IM) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ERIG Major Manufacturers Table 3. HRIG Major Manufacturers Table 4. Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Category II Exposure Major Manufacturers Table 6. Category III Exposure Major Manufacturers Table 7. Human Rabies Immunoglobulin (IM) Industry Trends Table 8. Human Rabies Immunoglobulin (IM) Industry Drivers Table 9. Human Rabies Immunoglobulin (IM) Industry Opportunities and Challenges Table 10. Human Rabies Immunoglobulin (IM) Industry Restraints Table 11. Global Human Rabies Immunoglobulin (IM) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Human Rabies Immunoglobulin (IM) Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Human Rabies Immunoglobulin (IM) Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2021-2026) Table 15. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2027-2032) Table 16. Global Human Rabies Immunoglobulin (IM) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Human Rabies Immunoglobulin (IM) Sales by Region (2021-2026) & (K Units) Table 18. Global Human Rabies Immunoglobulin (IM) Sales by Region (2027-2032) & (K Units) Table 19. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2021-2026) Table 20. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2027-2032) Table 21. Global Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Human Rabies Immunoglobulin (IM) Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Manufacturers (2021-2026) Table 25. Global Human Rabies Immunoglobulin (IM) Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 26. Global Human Rabies Immunoglobulin (IM) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Human Rabies Immunoglobulin (IM) Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Human Rabies Immunoglobulin (IM) Manufacturers, Product Type & Application Table 29. Global Human Rabies Immunoglobulin (IM) Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Human Rabies Immunoglobulin (IM) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Human Rabies Immunoglobulin (IM) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Human Rabies Immunoglobulin (IM) Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2021-2026) Table 36. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2027-2032) Table 37. Global Human Rabies Immunoglobulin (IM) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Human Rabies Immunoglobulin (IM) Sales by Type (2021-2026) & (K Units) Table 39. Global Human Rabies Immunoglobulin (IM) Sales by Type (2027-2032) & (K Units) Table 40. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2021-2026) Table 41. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2027-2032) Table 42. Global Human Rabies Immunoglobulin (IM) Price by Type (2021-2026) & (USD/Unit) Table 43. Global Human Rabies Immunoglobulin (IM) Price by Type (2027-2032) & (USD/Unit) Table 44. Global Human Rabies Immunoglobulin (IM) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Human Rabies Immunoglobulin (IM) Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2021-2026) Table 48. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2027-2032) Table 49. Global Human Rabies Immunoglobulin (IM) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Human Rabies Immunoglobulin (IM) Sales by Application (2021-2026) & (K Units) Table 51. Global Human Rabies Immunoglobulin (IM) Sales by Application (2027-2032) & (K Units) Table 52. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2021-2026) Table 53. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2027-2032) Table 54. Global Human Rabies Immunoglobulin (IM) Price by Application (2021-2026) & (USD/Unit) Table 55. Global Human Rabies Immunoglobulin (IM) Price by Application (2027-2032) & (USD/Unit) Table 56. CSL Behring Company Information Table 57. CSL Behring Business Overview Table 58. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 59. CSL Behring Human Rabies Immunoglobulin (IM) Product Portfolio Table 60. CSL Behring Recent Development Table 61. Grifols Company Information Table 62. Grifols Business Overview Table 63. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 64. Grifols Human Rabies Immunoglobulin (IM) Product Portfolio Table 65. Grifols Recent Development Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Sanofi Human Rabies Immunoglobulin (IM) Product Portfolio Table 70. Sanofi Recent Development Table 71. Sichuan Yuanda Shuyang Company Information Table 72. Sichuan Yuanda Shuyang Business Overview Table 73. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Portfolio Table 75. Sichuan Yuanda Shuyang Recent Development Table 76. CNBG Company Information Table 77. CNBG Business Overview Table 78. CNBG Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. CNBG Human Rabies Immunoglobulin (IM) Product Portfolio Table 80. CNBG Recent Development Table 81. Kamada Company Information Table 82. Kamada Business Overview Table 83. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Kamada Human Rabies Immunoglobulin (IM) Product Portfolio Table 85. Kamada Recent Development Table 86. CBPO Company Information Table 87. CBPO Business Overview Table 88. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. CBPO Human Rabies Immunoglobulin (IM) Product Portfolio Table 90. CBPO Recent Development Table 91. Shuanglin Bio Company Information Table 92. Shuanglin Bio Business Overview Table 93. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Portfolio Table 95. Shuanglin Bio Recent Development Table 96. Weiguang Bio Company Information Table 97. Weiguang Bio Business Overview Table 98. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Weiguang Bio Human Rabies Immunoglobulin (IM) Product Portfolio Table 100. Weiguang Bio Recent Development Table 101. Shanghai RAAS Company Information Table 102. Shanghai RAAS Business Overview Table 103. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Portfolio Table 105. Shanghai RAAS Recent Development Table 106. Bharat Serum Company Information Table 107. Bharat Serum Business Overview Table 108. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Bharat Serum Human Rabies Immunoglobulin (IM) Product Portfolio Table 110. Bharat Serum Recent Development Table 111. VINS Company Information Table 112. VINS Business Overview Table 113. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. VINS Human Rabies Immunoglobulin (IM) Product Portfolio Table 115. VINS Recent Development Table 116. North America Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2026) & (US$ Million) Table 117. North America Human Rabies Immunoglobulin (IM) Revenue by Type (2027-2032) & (US$ Million) Table 118. North America Human Rabies Immunoglobulin (IM) Sales by Type (2021-2026) & (K Units) Table 119. North America Human Rabies Immunoglobulin (IM) Sales by Type (2027-2032) & (K Units) Table 120. North America Human Rabies Immunoglobulin (IM) Sales Price by Type (2021-2026) & (USD/Unit) Table 121. North America Human Rabies Immunoglobulin (IM) Sales Price by Type (2027-2032) & (USD/Unit) Table 122. North America Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Human Rabies Immunoglobulin (IM) Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Human Rabies Immunoglobulin (IM) Sales by Application (2021-2026) & (K Units) Table 125. North America Human Rabies Immunoglobulin (IM) Sales by Application (2027-2032) & (K Units) Table 126. North America Human Rabies Immunoglobulin (IM) Sales Price by Application (2021-2026) & (USD/Unit) Table 127. North America Human Rabies Immunoglobulin (IM) Sales Price by Application (2027-2032) & (USD/Unit) Table 128. North America Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. North America Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. North America Human Rabies Immunoglobulin (IM) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 132. North America Human Rabies Immunoglobulin (IM) Sales by Country (2021-2026) & (K Units) Table 133. North America Human Rabies Immunoglobulin (IM) Sales by Country (2027-2032) & (K Units) Table 134. North America Human Rabies Immunoglobulin (IM) Sales Price by Country (2021-2026) & (USD/Unit) Table 135. North America Human Rabies Immunoglobulin (IM) Sales Price by Country (2027-2032) & (USD/Unit) Table 136. United States Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 137. Canada Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 138. Mexico Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 139. Europe Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2026) & (US$ Million) Table 140. Europe Human Rabies Immunoglobulin (IM) Revenue by Type (2027-2032) & (US$ Million) Table 141. Europe Human Rabies Immunoglobulin (IM) Sales by Type (2021-2026) & (K Units) Table 142. Europe Human Rabies Immunoglobulin (IM) Sales by Type (2027-2032) & (K Units) Table 143. Europe Human Rabies Immunoglobulin (IM) Sales Price by Type (2021-2026) & (USD/Unit) Table 144. Europe Human Rabies Immunoglobulin (IM) Sales Price by Type (2027-2032) & (USD/Unit) Table 145. Europe Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2026) & (US$ Million) Table 146. Europe Human Rabies Immunoglobulin (IM) Revenue by Application (2027-2032) & (US$ Million) Table 147. Europe Human Rabies Immunoglobulin (IM) Sales by Application (2021-2026) & (K Units) Table 148. Europe Human Rabies Immunoglobulin (IM) Sales by Application (2027-2032) & (K Units) Table 149. Europe Human Rabies Immunoglobulin (IM) Sales Price by Application (2021-2026) & (USD/Unit) Table 150. Europe Human Rabies Immunoglobulin (IM) Sales Price by Application (2027-2032) & (USD/Unit) Table 151. Europe Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Europe Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 155. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2021-2026) & (K Units) Table 156. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2027-2032) & (K Units) Table 157. Europe Human Rabies Immunoglobulin (IM) Sales Price by Country (2021-2026) & (USD/Unit) Table 158. Europe Human Rabies Immunoglobulin (IM) Sales Price by Country (2027-2032) & (USD/Unit) Table 159. Germany Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 160. France Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 161. U.K. Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 162. Italy Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 163. Russia Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 164. Spain Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 165. Netherlands Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 166. Switzerland Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 167. Sweden Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 168. Poland Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 169. China Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2026) & (US$ Million) Table 170. China Human Rabies Immunoglobulin (IM) Revenue by Type (2027-2032) & (US$ Million) Table 171. China Human Rabies Immunoglobulin (IM) Sales by Type (2021-2026) & (K Units) Table 172. China Human Rabies Immunoglobulin (IM) Sales by Type (2027-2032) & (K Units) Table 173. China Human Rabies Immunoglobulin (IM) Sales Price by Type (2021-2026) & (USD/Unit) Table 174. China Human Rabies Immunoglobulin (IM) Sales Price by Type (2027-2032) & (USD/Unit) Table 175. China Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2026) & (US$ Million) Table 176. China Human Rabies Immunoglobulin (IM) Revenue by Application (2027-2032) & (US$ Million) Table 177. China Human Rabies Immunoglobulin (IM) Sales by Application (2021-2026) & (K Units) Table 178. China Human Rabies Immunoglobulin (IM) Sales by Application (2027-2032) & (K Units) Table 179. China Human Rabies Immunoglobulin (IM) Sales Price by Application (2021-2026) & (USD/Unit) Table 180. China Human Rabies Immunoglobulin (IM) Sales Price by Application (2027-2032) & (USD/Unit) Table 181. Asia Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2026) & (US$ Million) Table 182. Asia Human Rabies Immunoglobulin (IM) Revenue by Type (2027-2032) & (US$ Million) Table 183. Asia Human Rabies Immunoglobulin (IM) Sales by Type (2021-2026) & (K Units) Table 184. Asia Human Rabies Immunoglobulin (IM) Sales by Type (2027-2032) & (K Units) Table 185. Asia Human Rabies Immunoglobulin (IM) Sales Price by Type (2021-2026) & (USD/Unit) Table 186. Asia Human Rabies Immunoglobulin (IM) Sales Price by Type (2027-2032) & (USD/Unit) Table 187. Asia Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2026) & (US$ Million) Table 188. Asia Human Rabies Immunoglobulin (IM) Revenue by Application (2027-2032) & (US$ Million) Table 189. Asia Human Rabies Immunoglobulin (IM) Sales by Application (2021-2026) & (K Units) Table 190. Asia Human Rabies Immunoglobulin (IM) Sales by Application (2027-2032) & (K Units) Table 191. Asia Human Rabies Immunoglobulin (IM) Sales Price by Application (2021-2026) & (USD/Unit) Table 192. Asia Human Rabies Immunoglobulin (IM) Sales Price by Application (2027-2032) & (USD/Unit) Table 193. Asia Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Asia Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Asia Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Asia Human Rabies Immunoglobulin (IM) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 197. Asia Human Rabies Immunoglobulin (IM) Sales by Country (2021-2026) & (K Units) Table 198. Asia Human Rabies Immunoglobulin (IM) Sales by Country (2027-2032) & (K Units) Table 199. Asia Human Rabies Immunoglobulin (IM) Sales Price by Country (2021-2026) & (USD/Unit) Table 200. Asia Human Rabies Immunoglobulin (IM) Sales Price by Country (2027-2032) & (USD/Unit) Table 201. Japan Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 202. South Korea Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 203. India Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 204. Australia Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 205. Taiwan Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 206. Southeast Asia Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 207. SAMEA Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2026) & (US$ Million) Table 208. SAMEA Human Rabies Immunoglobulin (IM) Revenue by Type (2027-2032) & (US$ Million) Table 209. SAMEA Human Rabies Immunoglobulin (IM) Sales by Type (2021-2026) & (K Units) Table 210. SAMEA Human Rabies Immunoglobulin (IM) Sales by Type (2027-2032) & (K Units) Table 211. SAMEA Human Rabies Immunoglobulin (IM) Sales Price by Type (2021-2026) & (USD/Unit) Table 212. SAMEA Human Rabies Immunoglobulin (IM) Sales Price by Type (2027-2032) & (USD/Unit) Table 213. SAMEA Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2026) & (US$ Million) Table 214. SAMEA Human Rabies Immunoglobulin (IM) Revenue by Application (2027-2032) & (US$ Million) Table 215. SAMEA Human Rabies Immunoglobulin (IM) Sales by Application (2021-2026) & (K Units) Table 216. SAMEA Human Rabies Immunoglobulin (IM) Sales by Application (2027-2032) & (K Units) Table 217. SAMEA Human Rabies Immunoglobulin (IM) Sales Price by Application (2021-2026) & (USD/Unit) Table 218. SAMEA Human Rabies Immunoglobulin (IM) Sales Price by Application (2027-2032) & (USD/Unit) Table 219. SAMEA Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. SAMEA Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. SAMEA Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. SAMEA Human Rabies Immunoglobulin (IM) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 223. SAMEA Human Rabies Immunoglobulin (IM) Sales by Country (2021-2026) & (K Units) Table 224. SAMEA Human Rabies Immunoglobulin (IM) Sales by Country (2027-2032) & (K Units) Table 225. SAMEA Human Rabies Immunoglobulin (IM) Sales Price by Country (2021-2026) & (USD/Unit) Table 226. SAMEA Human Rabies Immunoglobulin (IM) Sales Price by Country (2027-2032) & (USD/Unit) Table 227. Brazil Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 228. Argentina Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 229. Chile Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 230. Colombia Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 231. Peru Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 232. Saudi Arabia Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 233. Israel Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 234. UAE Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 235. Turkey Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 236. Iran Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 237. Egypt Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Table 238. Key Raw Materials Table 239. Raw Materials Key Suppliers Table 240. Human Rabies Immunoglobulin (IM) Distributors List Table 241. Human Rabies Immunoglobulin (IM) Customers List Table 242. Research Programs/Design for This Report Table 243. Authors List of This Report Table 244. Secondary Sources Table 245. Primary Sources List of Figures Figure 1. Human Rabies Immunoglobulin (IM) Image Figure 2. Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Rabies Immunoglobulin (IM) Market Size Share 2021 VS 2025 VS 2032 Figure 4. ERIG Image Figure 5. HRIG Image Figure 6. Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Human Rabies Immunoglobulin (IM) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Category II Exposure Image Figure 9. Category III Exposure Image Figure 10. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Human Rabies Immunoglobulin (IM) Revenue (2021-2032) & (US$ Million) Figure 12. Global Human Rabies Immunoglobulin (IM) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2021-2032) Figure 15. Global Human Rabies Immunoglobulin (IM) Sales (2021-2032) & (K Units) Figure 16. Global Human Rabies Immunoglobulin (IM) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Human Rabies Immunoglobulin (IM) Sales YoY (2021-2032) & (K Units) Figure 19. Europe Human Rabies Immunoglobulin (IM) Sales YoY (2021-2032) & (K Units) Figure 20. China Human Rabies Immunoglobulin (IM) Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Human Rabies Immunoglobulin (IM) Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Human Rabies Immunoglobulin (IM) Sales YoY (2021-2032) & (K Units) Figure 23. Global Human Rabies Immunoglobulin (IM) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Human Rabies Immunoglobulin (IM) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Human Rabies Immunoglobulin (IM) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2021-2032) Figure 29. Global Human Rabies Immunoglobulin (IM) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2021-2032) Figure 32. Global Human Rabies Immunoglobulin (IM) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2021-2032) Figure 35. Global Human Rabies Immunoglobulin (IM) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2021-2032) Figure 38. North America Human Rabies Immunoglobulin (IM) Revenue Share by Type (2021-2032) Figure 39. North America Human Rabies Immunoglobulin (IM) Sales Share by Type (2021-2032) Figure 40. North America Human Rabies Immunoglobulin (IM) Revenue Share by Application (2021-2032) Figure 41. North America Human Rabies Immunoglobulin (IM) Sales Share by Application (2021-2032) Figure 42. North America Human Rabies Immunoglobulin (IM) Revenue Share by Country (2021-2032) Figure 43. North America Human Rabies Immunoglobulin (IM) Sales Share by Country (2021-2032) Figure 44. Europe Human Rabies Immunoglobulin (IM) Revenue Share by Type (2021-2032) Figure 45. Europe Human Rabies Immunoglobulin (IM) Sales Share by Type (2021-2032) Figure 46. Europe Human Rabies Immunoglobulin (IM) Revenue Share by Application (2021-2032) Figure 47. Europe Human Rabies Immunoglobulin (IM) Sales Share by Application (2021-2032) Figure 48. Europe Human Rabies Immunoglobulin (IM) Revenue Share by Country (2021-2032) Figure 49. Europe Human Rabies Immunoglobulin (IM) Sales Share by Country (2021-2032) Figure 50. China Human Rabies Immunoglobulin (IM) Revenue Share by Type (2021-2032) Figure 51. China Human Rabies Immunoglobulin (IM) Sales Share by Type (2021-2032) Figure 52. China Human Rabies Immunoglobulin (IM) Revenue Share by Application (2021-2032) Figure 53. China Human Rabies Immunoglobulin (IM) Sales Share by Application (2021-2032) Figure 54. Asia Human Rabies Immunoglobulin (IM) Revenue Share by Type (2021-2032) Figure 55. Asia Human Rabies Immunoglobulin (IM) Sales Share by Type (2021-2032) Figure 56. Asia Human Rabies Immunoglobulin (IM) Revenue Share by Application (2021-2032) Figure 57. Asia Human Rabies Immunoglobulin (IM) Sales Share by Application (2021-2032) Figure 58. Asia Human Rabies Immunoglobulin (IM) Revenue Share by Country (2021-2032) Figure 59. Asia Human Rabies Immunoglobulin (IM) Sales Share by Country (2021-2032) Figure 60. SAMEA Human Rabies Immunoglobulin (IM) Revenue Share by Type (2021-2032) Figure 61. SAMEA Human Rabies Immunoglobulin (IM) Sales Share by Type (2021-2032) Figure 62. SAMEA Human Rabies Immunoglobulin (IM) Revenue Share by Application (2021-2032) Figure 63. SAMEA Human Rabies Immunoglobulin (IM) Sales Share by Application (2021-2032) Figure 64. SAMEA Human Rabies Immunoglobulin (IM) Revenue Share by Country (2021-2032) Figure 65. SAMEA Human Rabies Immunoglobulin (IM) Sales Share by Country (2021-2032) Figure 66. Human Rabies Immunoglobulin (IM) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Human Rabies Immunoglobulin (IM) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • ERIG
  • HRIG
Applications
  • Category II Exposure
  • Category III Exposure
Companies covered
  • CSL Behring
  • Grifols
  • Sanofi
  • Sichuan Yuanda Shuyang
  • CNBG
  • Kamada
  • CBPO
  • Shuanglin Bio
  • Weiguang Bio
  • Shanghai RAAS
  • Bharat Serum
  • VINS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Rabies Immunoglobulin (IM) Market by Type
  3. 1.2.1 Global Human Rabies Immunoglobulin (IM) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ERIG
  5. 1.2.3 HRIG
  6. 1.3 Human Rabies Immunoglobulin (IM) Market by Application
  7. 1.3.1 Global Human Rabies Immunoglobulin (IM) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Category II Exposure
  9. 1.3.3 Category III Exposure
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Human Rabies Immunoglobulin (IM) Market Dynamics
  1. 2.1 Human Rabies Immunoglobulin (IM) Industry Trends
  2. 2.2 Human Rabies Immunoglobulin (IM) Industry Drivers
  3. 2.3 Human Rabies Immunoglobulin (IM) Industry Opportunities and Challenges
  4. 2.4 Human Rabies Immunoglobulin (IM) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Rabies Immunoglobulin (IM) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Rabies Immunoglobulin (IM) Revenue by Region
  3. 3.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Rabies Immunoglobulin (IM) Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Rabies Immunoglobulin (IM) Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Rabies Immunoglobulin (IM) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Rabies Immunoglobulin (IM) Sales by Region
  9. 3.4.1 Global Human Rabies Immunoglobulin (IM) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Rabies Immunoglobulin (IM) Sales by Region (2021-2026)
  11. 3.4.3 Global Human Rabies Immunoglobulin (IM) Sales by Region (2027-2032)
  12. 3.4.4 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Rabies Immunoglobulin (IM) Revenue by Manufacturers
  2. 4.1.1 Global Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Rabies Immunoglobulin (IM) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Rabies Immunoglobulin (IM) Sales by Manufacturers
  6. 4.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Rabies Immunoglobulin (IM) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Rabies Immunoglobulin (IM) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Rabies Immunoglobulin (IM) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Rabies Immunoglobulin (IM) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Rabies Immunoglobulin (IM) Manufacturers, Product Type & Application
  13. 4.7 Global Human Rabies Immunoglobulin (IM) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Rabies Immunoglobulin (IM) Market CR5 and HHI
  16. 4.8.2 2025 Human Rabies Immunoglobulin (IM) Tier 1, Tier 2, and Tier 3
5 Human Rabies Immunoglobulin (IM) Market by Type
  1. 5.1 Global Human Rabies Immunoglobulin (IM) Revenue by Type
  2. 5.1.1 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Rabies Immunoglobulin (IM) Sales by Type
  6. 5.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Rabies Immunoglobulin (IM) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Rabies Immunoglobulin (IM) Price by Type
6 Human Rabies Immunoglobulin (IM) Market by Application
  1. 6.1 Global Human Rabies Immunoglobulin (IM) Revenue by Application
  2. 6.1.1 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Rabies Immunoglobulin (IM) Sales by Application
  6. 6.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Rabies Immunoglobulin (IM) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Rabies Immunoglobulin (IM) Price by Application
7 Company Profiles
  1. 7.1 CSL Behring
  2. 7.1.1 CSL Behring Company Information
  3. 7.1.2 CSL Behring Business Overview
  4. 7.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Product Portfolio
  6. 7.1.5 CSL Behring Recent Developments
  7. 7.2 Grifols
  8. 7.2.1 Grifols Company Information
  9. 7.2.2 Grifols Business Overview
  10. 7.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Grifols Human Rabies Immunoglobulin (IM) Product Portfolio
  12. 7.2.5 Grifols Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Human Rabies Immunoglobulin (IM) Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Sichuan Yuanda Shuyang
  20. 7.4.1 Sichuan Yuanda Shuyang Company Information
  21. 7.4.2 Sichuan Yuanda Shuyang Business Overview
  22. 7.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Portfolio
  24. 7.4.5 Sichuan Yuanda Shuyang Recent Developments
  25. 7.5 CNBG
  26. 7.5.1 CNBG Company Information
  27. 7.5.2 CNBG Business Overview
  28. 7.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CNBG Human Rabies Immunoglobulin (IM) Product Portfolio
  30. 7.5.5 CNBG Recent Developments
  31. 7.6 Kamada
  32. 7.6.1 Kamada Company Information
  33. 7.6.2 Kamada Business Overview
  34. 7.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Kamada Human Rabies Immunoglobulin (IM) Product Portfolio
  36. 7.6.5 Kamada Recent Developments
  37. 7.7 CBPO
  38. 7.7.1 CBPO Company Information
  39. 7.7.2 CBPO Business Overview
  40. 7.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CBPO Human Rabies Immunoglobulin (IM) Product Portfolio
  42. 7.7.5 CBPO Recent Developments
  43. 7.8 Shuanglin Bio
  44. 7.8.1 Shuanglin Bio Company Information
  45. 7.8.2 Shuanglin Bio Business Overview
  46. 7.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Portfolio
  48. 7.8.5 Shuanglin Bio Recent Developments
  49. 7.9 Weiguang Bio
  50. 7.9.1 Weiguang Bio Company Information
  51. 7.9.2 Weiguang Bio Business Overview
  52. 7.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Product Portfolio
  54. 7.9.5 Weiguang Bio Recent Developments
  55. 7.10 Shanghai RAAS
  56. 7.10.1 Shanghai RAAS Company Information
  57. 7.10.2 Shanghai RAAS Business Overview
  58. 7.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Portfolio
  60. 7.10.5 Shanghai RAAS Recent Developments
  61. 7.11 Bharat Serum
  62. 7.11.1 Bharat Serum Company Information
  63. 7.11.2 Bharat Serum Business Overview
  64. 7.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bharat Serum Human Rabies Immunoglobulin (IM) Product Portfolio
  66. 7.11.5 Bharat Serum Recent Developments
  67. 7.12 VINS
  68. 7.12.1 VINS Company Information
  69. 7.12.2 VINS Business Overview
  70. 7.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 VINS Human Rabies Immunoglobulin (IM) Product Portfolio
  72. 7.12.5 VINS Recent Developments
8 North America
  1. 8.1 North America Human Rabies Immunoglobulin (IM) Market Size by Type
  2. 8.1.1 North America Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Rabies Immunoglobulin (IM) Sales by Type (2021-2032)
  4. 8.1.3 North America Human Rabies Immunoglobulin (IM) Price by Type (2021-2032)
  5. 8.2 North America Human Rabies Immunoglobulin (IM) Market Size by Application
  6. 8.2.1 North America Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Rabies Immunoglobulin (IM) Sales by Application (2021-2032)
  8. 8.2.3 North America Human Rabies Immunoglobulin (IM) Price by Application (2021-2032)
  9. 8.3 North America Human Rabies Immunoglobulin (IM) Market Size by Country
  10. 8.3.1 North America Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Rabies Immunoglobulin (IM) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Rabies Immunoglobulin (IM) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Rabies Immunoglobulin (IM) Market Size by Type
  2. 9.1.1 Europe Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Rabies Immunoglobulin (IM) Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Rabies Immunoglobulin (IM) Price by Type (2021-2032)
  5. 9.2 Europe Human Rabies Immunoglobulin (IM) Market Size by Application
  6. 9.2.1 Europe Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Rabies Immunoglobulin (IM) Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Rabies Immunoglobulin (IM) Price by Application (2021-2032)
  9. 9.3 Europe Human Rabies Immunoglobulin (IM) Market Size by Country
  10. 9.3.1 Europe Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Rabies Immunoglobulin (IM) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Rabies Immunoglobulin (IM) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Rabies Immunoglobulin (IM) Market Size by Type
  2. 10.1.1 China Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2032)
  3. 10.1.2 China Human Rabies Immunoglobulin (IM) Sales by Type (2021-2032)
  4. 10.1.3 China Human Rabies Immunoglobulin (IM) Price by Type (2021-2032)
  5. 10.2 China Human Rabies Immunoglobulin (IM) Market Size by Application
  6. 10.2.1 China Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2032)
  7. 10.2.2 China Human Rabies Immunoglobulin (IM) Sales by Application (2021-2032)
  8. 10.2.3 China Human Rabies Immunoglobulin (IM) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Rabies Immunoglobulin (IM) Market Size by Type
  2. 11.1.1 Asia Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Rabies Immunoglobulin (IM) Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Rabies Immunoglobulin (IM) Price by Type (2021-2032)
  5. 11.2 Asia Human Rabies Immunoglobulin (IM) Market Size by Application
  6. 11.2.1 Asia Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Rabies Immunoglobulin (IM) Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Rabies Immunoglobulin (IM) Price by Application (2021-2032)
  9. 11.3 Asia Human Rabies Immunoglobulin (IM) Market Size by Country
  10. 11.3.1 Asia Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Rabies Immunoglobulin (IM) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Rabies Immunoglobulin (IM) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Rabies Immunoglobulin (IM) Market Size by Type
  2. 12.1.1 SAMEA Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Rabies Immunoglobulin (IM) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Rabies Immunoglobulin (IM) Price by Type (2021-2032)
  5. 12.2 SAMEA Human Rabies Immunoglobulin (IM) Market Size by Application
  6. 12.2.1 SAMEA Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Rabies Immunoglobulin (IM) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Rabies Immunoglobulin (IM) Price by Application (2021-2032)
  9. 12.3 SAMEA Human Rabies Immunoglobulin (IM) Market Size by Country
  10. 12.3.1 SAMEA Human Rabies Immunoglobulin (IM) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Rabies Immunoglobulin (IM) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Rabies Immunoglobulin (IM) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Rabies Immunoglobulin (IM) Value Chain Analysis
  2. 13.1.1 Human Rabies Immunoglobulin (IM) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Rabies Immunoglobulin (IM) Production Mode & Process
  6. 13.2 Human Rabies Immunoglobulin (IM) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Rabies Immunoglobulin (IM) Distributors
  9. 13.2.3 Human Rabies Immunoglobulin (IM) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst